Skip to main content
Log in

Prevalence and risk factors associated with chronic kidney disease in a Uygur adult population from Urumqi

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

Evaluating the prevalence of kidney damage according to population-based studies in different communities has been limited in developing countries. We conducted a population-based screening study in Uygur people of Urumqi, aiming to identify the prevalence and associated risk factors of chronic kidney disease (CKD) in Uygur populations. A total of 2576 residents (>18 years) from four districts of Urumqi were interviewed from June 2007 to January 2009 and tested for haematuria, albuminuria and reduced renal function. Associations between age, gender, smoking, diabetes mellitus, hypertension, hyperuricaemia and kidney damage were examined. There were 2576 subjects enrolled in this study. After age correction, the prevalence of albuminuria, haematuria and reduced estimated glomerular filtration rate (eGFR) was 3.58%, 2.26% and 1.03%, respectively. Approximately 5.65% of the sample population had at least one indicator of kidney damage. Age, diabetes mellitus, hypercholesteremia, hyperuricaemia and hyperlipidaemia were independently associated with CKD. In the general Uygur adult population from Urumqi, 5.65% had either proteinuria, haematuria or reduced eGFR, indicating the presence of kidney damage, with an awareness of only 1.05%. The high prevalence and low awareness of CKD in this population suggest an urgent need for CKD prevention programs in Uygur people.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chadban SJ, Brigand EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol, 2003,14(7 Suppl 2): 131–S138

    Article  Google Scholar 

  2. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis, 2003, 1(1):1–12

    Article  Google Scholar 

  3. Hallan SI, Coresh J, Astor BC, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006,17(8):2275–2284

    Article  PubMed  Google Scholar 

  4. van Dijk PC, Jager KJ, de Charro F, et al. Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant, 2001,16(6):1120–1129

    Article  PubMed  Google Scholar 

  5. Xue JL, Ma JZ, Louis TA, et al. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol, 2001,12(12): 2753–2758

    CAS  PubMed  Google Scholar 

  6. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classificatioan of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int, 2005,67(6):2089–100

    Article  PubMed  Google Scholar 

  7. Lord GM, Tagore R, Cook T, et al. Nephropathy caused by Chinese herbs in the UK. Lancet 1999,354(9177): 81–482

    Article  Google Scholar 

  8. Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol, 2006, 7(10):2937–2944

    Article  Google Scholar 

  9. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis, 2002,39(2 Suppl 1):S1–S266

    Google Scholar 

  10. Zhang L, Zhang P, Wang F, et al. Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis, 2008,51(3):373–384

    Article  PubMed  Google Scholar 

  11. Clase CM, Kiberd BA, Garg AX, et al. Relationship between glomerular filtration rate and the prevalence of metabolic abnormalities: results from the Third National Health and Nutrition Examination Survey (NHANES III). Nehron Clin Pract, 2007,105(4):c178–184

    Article  Google Scholar 

  12. Zhang L, Zuo L, Xu G, et al. Community-based screening for chronic kidney disease among populations older than 40 years in Beijing. Nephrol Dial Transplant 2007,22(4):1093–109

    Article  PubMed  Google Scholar 

  13. Chen J, Wildman RP, Gu D, et al. Prevalence of decreased kidney function in Chinese adults aged 35 to 74 years. Kidney Int, 2005,68(6):2837–2845

    Article  PubMed  Google Scholar 

  14. Li PK, Kwan BC, Leung CB, et al. Prevalence of silent kidney disease in Hong Kong: The screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program. Kidney Int Suppl, 2005,(94): S36–S40

  15. Shen P, He L, Li Y, et al. Natural history and proenostic factors of IgA nephropathy presented with isotated microscoptc hematuria in Chinese patients. Nephron Clin Pract, 2007,106(4):c157–c161

    Article  CAS  PubMed  Google Scholar 

  16. Koyama A, Igarashi M, Kobayashi M: Natural history and risk factors for immunoglobulin A nephropathy. Am J Kidney Dis, 1997,29(4):526–532.

    Article  CAS  PubMed  Google Scholar 

  17. Chow KM, Kwan BC, Li PK, et al. Asymptomatic isolated microscopic haematuria: long-term follow-up. QJM, 2004,97(11):739–745

    Article  CAS  PubMed  Google Scholar 

  18. Yamagata K, Takahashi H, Tomida C, et al. Proenosis of asymptomatic hematuria and/or proteinuria in men. High prevalence of IgA nephropathy among proteinuric patients found in mass screening. Nephron, 2002, 91(1):34–42

    Google Scholar 

  19. Sytjanen J, Mustonen J, Pasternack A, et al. Hyper-triglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant, 2000,15(1):34–42

    Article  Google Scholar 

  20. Iseki K, Oshiro S, Tozawa M, et al. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res, 2001, 24(6): 691–697

    Article  CAS  PubMed  Google Scholar 

  21. Kanellis J, Feig DI, Johnson RJ, et al. Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed. Nephrology (Carlton), 2004,9(6):394–399

    Article  Google Scholar 

  22. Siu YP, Leung KT, Tong MK, et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 2006,47(1):51–59

    Article  CAS  PubMed  Google Scholar 

  23. Prevalence of chronic kidney disease and associated risk factors-United States, 1999–2004. MMWR Morb Mortal Wkly Rep, 2007,56(8):161–165

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Gang Xu  (徐 钢) or Xiaocheng Liu  (刘晓城).

Additional information

This project was supported by grants from Scientific and Technologic Committee of Urumqi, China (No. Y06231006), and from frontier supporting science and technology projects of Xinjiang Uygur Autonomous Region, China (No. 200840102-38).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lu, C., Zhao, H., Xu, G. et al. Prevalence and risk factors associated with chronic kidney disease in a Uygur adult population from Urumqi. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 30, 604–610 (2010). https://doi.org/10.1007/s11596-010-0550-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-010-0550-1

Key words

Navigation